Literature DB >> 11890476

Immune responses: adverse versus non-adverse effects.

Ian Kimber1, Rebecca J Dearman.   

Abstract

The adaptive immune system in vertebrates has evolved to provide host resistance to infectious microorganisms and malignant disease. Normal immune function and the induction of specific immune responses require the orchestrated interaction between cells and molecules both within and outside the lymphoid system. Immunotoxicology can be defined as the study of adverse health effects that may result from the interaction of xenobiotics with the immune system. In general terms such effects can take one of two forms. The first of these is immunotoxicity (or immunosuppression) where there is a perturbation of, or damage to, one or more components of the immune system resulting in impaired immune function and reduced host resistance. The design and interpretation of experimental immunotoxicity studies and the investigation of clinical immunosuppression require consideration of the relationship between changes in the structure and/or function of discrete components of the immune system and holistic changes in the susceptibility to infectious and malignant disease. The other main way in which chemicals may cause adverse health effects secondary to interaction with the immune system is through stimulation of specific immune responses that result in allergic disease. Allergy to chemicals and proteins can take many forms, including allergic contact dermatitis, allergic sensitization of the respiratory tract (associated with rhinitis and/or asthma), systemic allergic reactions (associated frequently with drug treatment), and gastrointestinal disease. Here there is a need to distinguish between immunogenic responses per se and those immune responses that are of sufficient vigor and of the quality necessary to provoke allergic sensitization. The purpose of this article is to explore the extent to which distinctions can be drawn between adverse and nonadverse effects in the context of immunotoxicity and allergy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890476     DOI: 10.1080/01926230252824707

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  3 in total

1.  Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

2.  Environmental and behavioral changes may influence the exposure of an Arctic apex predator to pathogens and contaminants.

Authors:  Todd C Atwood; Colleen Duncan; Kelly A Patyk; Pauline Nol; Jack Rhyan; Matthew McCollum; Melissa A McKinney; Andrew M Ramey; Camila K Cerqueira-Cézar; Oliver C H Kwok; Jitender P Dubey; Steven Hennager
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

Review 3.  Assessing Fish Immunotoxicity by Means of In Vitro Assays: Are We There Yet?

Authors:  Helmut Segner; Kristina Rehberger; Christyn Bailey; Jun Bo
Journal:  Front Immunol       Date:  2022-02-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.